Search Results - Taha Merghoub
- Showing 1 - 20 results of 121
- Go to Next Page
-
1
The importance of animal models in tumor immunity and immunotherapy by Sadna Budhu, Jedd D. Wolchok, Taha Merghoub
Published 2014Revisão -
2
-
3
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies by Roberta Zappasodi, Taha Merghoub, Jedd D. Wolchok
Published 2018Errata/Corrigenda -
4
-
5
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressi... by Rikke Holmgaard, Dmitriy Zamarin, Alexander M. Lesokhin, Taha Merghoub, Jedd D. Wolchok
Published 2016Artigo -
6
-
7
-
8
-
9
-
10
-
11
-
12
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity by Dmitriy Zamarin, Rikke Holmgaard, Jacob Ricca, Tamar Plitt, Peter Palese, Padmanee Sharma, Taha Merghoub, Jedd D. Wolchok, James P. Allison
Published 2017Artigo -
13
-
14
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells by Peihong Dai, Weiyi Wang, Ning Yang, Cristian Serna‐Tamayo, Jacob Ricca, Dmitriy Zamarin, Stewart Shuman, Taha Merghoub, Jedd D. Wolchok, Liang Deng
Published 2017Artigo -
15
-
16
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity by Marcela V. Maus, Jason Plotkin, Gopinadh Jakka, Guillaume B. E. Stewart-Jones, Isabelle Rivière, Taha Merghoub, Jedd D. Wolchok, Christoph Renner, Michel Sadelain
Published 2016Artigo -
17
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs by Takeshi Nakahara, Hiroshi Uchi, Alexander M. Lesokhin, Francesca Avogadri, Gabrielle Rizzuto, Daniel Hirschhorn-Cymerman, Katherine S. Panageas, Taha Merghoub, Jedd D. Wolchok, Alan N. Houghton
Published 2010Artigo -
18
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity by Francesca Avogadri, Taha Merghoub, Maureen F. Maughan, Daniel Hirschhorn-Cymerman, J. Glenn Morris, Erika Ritter, Robert A. Olmsted, Alan N. Houghton, Jedd D. Wolchok
Published 2010Artigo -
19
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis by Daniel Hirschhorn-Cymerman, Gabrielle Rizzuto, Taha Merghoub, Adam D. Cohen, Francesca Avogadri, Alexander M. Lesokhin, Andrew D. Weinberg, Jedd D. Wolchok, Alan N. Houghton
Published 2009Artigo -
20
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy by Rikke Holmgaard, Alexandra Brachfeld, Billel Gasmi, David R. Jones, Marissa S. Mattar, Thompson N. Doman, Mary Y. Murphy, David Schaer, Jedd D. Wolchok, Taha Merghoub
Published 2016Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Immunology
Immune system
Medicine
Immunotherapy
Internal medicine
Cancer
Genetics
Receptor
Gene
Biochemistry
T cell
Blockade
Cell biology
CD8
Immune checkpoint
Melanoma
Oncology
In vitro
Antigen
Cytotoxic T cell
Cancer immunotherapy
Tumor microenvironment
Chemistry
Lung cancer
Pathology
Mutation
Antibody
Computational biology